Skip to main content
. 2013 Nov 4;13:1041. doi: 10.1186/1471-2458-13-1041

Table 2.

HPV prevalence in participants from central Brazil

  HPV positive participants
 Multiple HPV positive participants
n % (95% CI) n % (95% CI)
HPV
 121
 28.0 (23.9-32.5)
 54
 100
One HPV type
 67
 15.5 (12.3-19.4)
 -
 -
Multiple HPV types
 54
 12.5 (9.6-16.1)
 -
 -
HR-HPV
 107
 24.8 (20.8-29.2)
 53
 98.1 (90.1-100.0)
LR-HPV
 32
 7.4 (5.2-10.4
 19
 5.8 (3.6-9.0)
HPV 16
 29
 6.7 (4.6-9.6)
 21
 38.9 (25.9-53.1)
HPV 51
 22
 5.1 (3.3-7.7)
 18
 33.3 (21.1-47.5)
HPV 31
 20
 4.6 (2.9-7.2)
 12
 22.0 (12.0-35.6)
HPV 52
 18
 4.2 (2.6-6.6)
 10
 18.5 (9.3-31.4)
HPV 18
 15
 3.5 (2.0-5.8)
 12
 22.2 (12.0-35.6)
HPV 53
 11
 2.5 (1.3-4.6)
 11
 20.4 (10.6-36.5)
HPV 58
 10
 2.3 (1.2-4.4)
 8
 14.8 (6.6-27.1)
HPV 39
 9
 2.1 (1.0-4,1)
 8
 14.8 (6.6-27.1)
HPV 6
 7
 1.6 (0.7-3.5)
 6
 11.1 (4.2-22.6)
HPV 45
 6
 1.4 (0.6-3.2)
 1
 1.9 (0.0-9.9)
HPV 66
 6
 1.4 (0.6-3.2)
 3
 5.6 (1.2-15.4)
HPV 73
 6
 1.4 (0.6-3.2)
 2
 3.7 (0.5-12.7)
HPV 42
 5
 1.2 (0.4-2.8)
 3
 5.6 (1.2-15.4)
HPV 54
 5
 1.2 (0.4-2.8)
 2
 3.7 (0.5-12.7)
HPV 26
 4
 0.9 (0.3-2.5)
 2
 3.7 (0.5-12.7)
HPV 33
 4
 0.9 (0.3-2.5)
 3
 5.6 (1.2-15.4)
HPV 56
 4
 0.9 (0.3-2.5)
 2
 3.7 (0.5-12.7)
HPV 68
 4
 0.9 (0.3-2.5)
 3
 5.6 (1.2-15.4)
HPV 40
 3
 0.7 (0.2-2.2)
 1
 1.9 (0.0-9.9)
HPV 84
 3
 0.7 (0.2-2.2)
 3
 5.6 (1.2-15.4)
HPV 35
 2
 0.5 (0.1-1.8)
 2
 3.7 (0.5-12.7)
HPV 70
 2
 0.5 (0.1-1.8)
 0
 -
HPV 55
 2
 0.5 (0.1-1.8)
 1
 1.9 (0.0-9.9)
HPV 61
 2
 0.5 (0.1-1.8)
 0
 -
HPV 62
 2
 0.5 (0.1-1.8)
 2
 3.7 (0.5-12.7)
HPV 59
 1
 0.2 (0.0-1.5)
 1
 1.9 (0.0-9.9)
HPV 82
 1
 0.2 (0.0-1.5)
 1
 1.9 (0.0-9.9)
HPV 11
 1
 0.2 (0.0-1.5)
 0
 -
HPV 89
 1
 0.2 (0.0-1.5)
 1
 1.9 (0.0-9.9)
HPV 44 1 0.2 (0.0-1.5) 0 -

HPV: human papillomavirus; CI: confidence interval; n: number of participants; HR-HPV: high-risk HPV; LR-HPV: low-risk HPV.